|
Drug Therapy, Other
Citations 1-10 of 113 total displayed.
|
Most recent content
(1 Nov 2009):
|
- Controversies in Neurology
The Value of Specifying Brand-name Antiepileptic Drugs
- Yu-tze Ng
Arch Neurol 2009; 66: 1415-1416.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
- Lorie D. Hamiwka
Arch Neurol 2009; 66: 1417-1418.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
The Cost of Gullibility
- E. S. Roach
Arch Neurol 2009; 66: 1418-1420.
[Extract]
[Full text]
[PDF]
|
Past content
(since Sep 1999):
|
- Editorials
Immunotherapy for Multiple Sclerosis: The Curious Case of Interferon Beta
- Olaf Stüve; Richard M. Ransohoff
Arch Neurol 2009; 66: 1193-1194.
[Extract]
[Full text]
[PDF]
- Neurological Reviews
Promising Strategies for the Prevention of Dementia
- Laura E. Middleton; Kristine Yaffe
Arch Neurol 2009; 66: 1210-1215.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
- Sabine Cepok; Herbert Schreiber; Steve Hoffmann; Dun Zhou; Oliver Neuhaus; Gloria von Geldern; Sonja Hochgesand; Stefan Nessler; Veith Rothhammer; Michael Lang; Hans-Peter Hartung; Bernhard Hemmer
Arch Neurol 2009; 66: 1216-1223.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Seizure Relapse and Development of Drug Resistance Following Long-term Seizure Remission
- Yitzhak Schiller
Arch Neurol 2009; 66: 1233-1239.
[Abstract]
[Full text]
[PDF]
- Book Reviews
Headache and Facial Pain: What Do I Do Now?
- Ulrike Bingel
Arch Neurol 2009; 66: 1297.
[Extract]
[Full text]
[PDF]
- Neurological Reviews
Preventive Antibiotics for Infections in Acute Stroke: A Systematic Review and Meta-analysis
- Diederik van de Beek; Eelco F. M. Wijdicks; Frederique H. Vermeij; Rob J. de Haan; Jan M. Prins; Lodewijk Spanjaard; Diederik W. J. Dippel; Paul J. Nederkoorn
Arch Neurol 2009; 66: 1076-1081.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience
- Sotirios A. Parashos; Christopher J. Swearingen; Kevin M. Biglan; Ivan Bodis-Wollner; Grace S. Liang; G. Webster Ross; Barbara C. Tilley; Lisa M. Shulman; for the NET-PD Investigators
Arch Neurol 2009; 66: 1099-1104.
[Abstract]
[Full text]
[PDF]
|
|
